Related Experiment Videos
Modulating signaling pathways in hypertrophy and heart failure by gene transfer
Fawzia Huq1, Federica Del Monte, Roger J Hajjar
1Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02129, USA.
Journal of Cardiac Failure
|January 30, 2003
Summary
Adenoviral gene transfer enables precise manipulation of cardiac signaling pathways. This approach advances understanding of heart failure mechanisms like hypertrophy and apoptosis, offering therapeutic potential.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Gene Therapy
Background:
- Gene transfer to the heart is an emerging therapeutic and research strategy.
- Adenoviral vectors facilitate targeted manipulation of intracellular signaling pathways.
- Understanding heart failure pathophysiology requires precise definition of molecular targets.
Purpose of the Study:
- To review recent advancements in myocardial gene transfer.
- To emphasize the role of adenoviral gene transfer in elucidating cardiac pathophysiology.
- To explore how signal transduction pathway manipulation aids in defining abnormal cardiac phenotypes.
Main Methods:
- Utilizing adenoviral vectors for gene transfer in cardiac research.
- Overexpressing or under-expressing specific proteins to probe signaling pathways.
- Analyzing the impact on intracellular signaling in cardiac models.
Main Results:
- Adenoviral gene transfer allows specific probing of complex signaling pathways.
- Manipulation of pathways has precisely defined roles of molecular targets.
- Insights gained into hypertrophy, contractile dysfunction, and apoptosis in cardiac failure.
Conclusions:
- Adenoviral gene transfer is a powerful tool for studying heart failure.
- This technique enhances understanding of molecular mechanisms underlying cardiac dysfunction.
- Advances in gene transfer offer potential for novel therapeutic strategies in cardiology.